Takeda Cholesterol Drug Filing Set Back Due To Liver Enzyme Data

Takeda had planned to file TAK-475 in the first quarter of 2008 but is now awaiting additional study data.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet